524 related articles for article (PubMed ID: 23433458)
1. Eicosanoids in metabolic syndrome.
Hardwick JP; Eckman K; Lee YK; Abdelmegeed MA; Esterle A; Chilian WM; Chiang JY; Song BJ
Adv Pharmacol; 2013; 66():157-266. PubMed ID: 23433458
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
Manco M
J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
[TBL] [Abstract][Full Text] [Related]
3. JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease.
Tarantino G; Caputi A
World J Gastroenterol; 2011 Sep; 17(33):3785-94. PubMed ID: 21987620
[TBL] [Abstract][Full Text] [Related]
4. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases.
Francisco V; Ruiz-Fernández C; Pino J; Mera A; González-Gay MA; Gómez R; Lago F; Mobasheri A; Gualillo O
Biochem Pharmacol; 2019 Jul; 165():196-206. PubMed ID: 30910694
[TBL] [Abstract][Full Text] [Related]
5. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.
Qureshi K; Abrams GA
World J Gastroenterol; 2007 Jul; 13(26):3540-53. PubMed ID: 17659704
[TBL] [Abstract][Full Text] [Related]
6. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.
Pacifico L; Nobili V; Anania C; Verdecchia P; Chiesa C
World J Gastroenterol; 2011 Jul; 17(26):3082-91. PubMed ID: 21912450
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
Lim S; Taskinen MR; Borén J
Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih M; Jornayvaz FR
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors.
Francque S; Szabo G; Abdelmalek MF; Byrne CD; Cusi K; Dufour JF; Roden M; Sacks F; Tacke F
Nat Rev Gastroenterol Hepatol; 2021 Jan; 18(1):24-39. PubMed ID: 33093663
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P; Hellerbrand C
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links.
Zafar U; Khaliq S; Ahmad HU; Manzoor S; Lone KP
Hormones (Athens); 2018 Sep; 17(3):299-313. PubMed ID: 30171523
[TBL] [Abstract][Full Text] [Related]
12. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
[TBL] [Abstract][Full Text] [Related]
13. The Eicosanoids, Redox-Regulated Lipid Mediators in Immunometabolic Disorders.
Araújo AC; Wheelock CE; Haeggström JZ
Antioxid Redox Signal; 2018 Jul; 29(3):275-296. PubMed ID: 28978222
[TBL] [Abstract][Full Text] [Related]
14. Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial.
Feng RN; Niu YC; Sun XW; Li Q; Zhao C; Wang C; Guo FC; Sun CH; Li Y
Diabetologia; 2013 May; 56(5):985-94. PubMed ID: 23361591
[TBL] [Abstract][Full Text] [Related]
15. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease.
Coronel-Castillo CE; Qi X; Contreras-Carmona J; Ramírez-Pérez OL; Méndez-Sánchez N
Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):531-540. PubMed ID: 30905208
[TBL] [Abstract][Full Text] [Related]
17. The metabolic cascade leading to eicosanoid precursors--desaturases, elongases, and phospholipases A2--is altered in Zucker fatty rats.
Fèvre C; Bellenger S; Pierre AS; Minville M; Bellenger J; Gresti J; Rialland M; Narce M; Tessier C
Biochim Biophys Acta; 2011 Jun; 1811(6):409-17. PubMed ID: 21172452
[TBL] [Abstract][Full Text] [Related]
18. Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
Katsiki N; Perez-Martinez P; Anagnostis P; Mikhailidis DP; Karagiannis A
Curr Vasc Pharmacol; 2018; 16(3):219-227. PubMed ID: 28669328
[TBL] [Abstract][Full Text] [Related]
19. Impact of Obesity and Metabolic Syndrome on Immunity.
Andersen CJ; Murphy KE; Fernandez ML
Adv Nutr; 2016 Jan; 7(1):66-75. PubMed ID: 26773015
[TBL] [Abstract][Full Text] [Related]
20. Eicosanoids and renal damage in cardiometabolic syndrome.
Imig JD
Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):165-74. PubMed ID: 18248310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
